×
About 742 results

ALLMedicine™ Pacemakers Center

Research & Reviews  349 results

Incidence of pacing-induced cardiomyopathy in pacemaker-dependent patients is lower wit...
https://doi.org/10.1111/jce.14814
Journal of Cardiovascular Electrophysiology REFERENCES; Sanchez R, Nadkarni A et. al.

Nov 18th, 2020 - Frequent right AQ4ventricular pacing (≥40%) with a transvenous pacemaker (TVP) is associated with the risk of pacing-induced cardiomyopathy (PICM). Leadless pacemakers (LPs) have distinct physical and mechanical differences from TVP. The risk of P...

Tine-Based Leadless Pacemaker: Strategies for Safe Implantation in Unconventional Clini...
https://doi.org/10.1016/j.jacep.2020.08.021
JACC. Clinical Electrophysiology; Okabe T, Afzal MR et. al.

Oct 23rd, 2020 - Leadless pacemakers (LPs) have emerged as a meaningful alternative to transvenous pacemakers for single-ventricular pacing. LPs eliminate many of lead- and pocket-associated complications observed with transvenous pacemakers. Owing to the lack of ...

VVI pacing with normal QRS duration and ventricular function: MOST trial findings relev...
https://doi.org/10.1111/pace.14100
Pacing and Clinical Electrophysiology : PACE REFERENCES; Loring Z, North R et. al.

Oct 21st, 2020 - Leadless pacemakers (LPs) provide ventricular pacing without the risks associated with transvenous leads and device pockets. LPs are appealing for patients who need pacing, but do not need defibrillator or cardiac resynchronization therapy. Most i...

Ten year trends in cardiac implantable electronic devices in New Zealand: a national da...
https://doi.org/10.1111/imj.15103
Internal Medicine Journal; Foo FS, Stiles MK et. al.

Oct 18th, 2020 - Implant rates for cardiac implantable electronic devices (CIED), including permanent pacemakers (PPM) and implantable cardioverter defibrillators (ICD), have increased globally in recent decades. This is the first national study providing a contem...

Seventeen-year trend (2001-2017) in pacemaker and implantable cardioverter-defibrillato...
https://doi.org/10.1016/j.ejim.2020.09.003
European Journal of Internal Medicine; Zecchin M, Torre M et. al.

Sep 16th, 2020 - To analyze temporal trends (2001 -2017) of Pacemakers (PM) and Implantable Cardioverter-Defibrillators (ICD) procedures in Italy, according to the national Hospital Discharge Database (HDD). Frequency and implant rate (IR) in the Italian populatio...

see more →

Clinicaltrials.gov  373 results

Incidence of pacing-induced cardiomyopathy in pacemaker-dependent patients is lower wit...
https://doi.org/10.1111/jce.14814
Journal of Cardiovascular Electrophysiology REFERENCES; Sanchez R, Nadkarni A et. al.

Nov 18th, 2020 - Frequent right AQ4ventricular pacing (≥40%) with a transvenous pacemaker (TVP) is associated with the risk of pacing-induced cardiomyopathy (PICM). Leadless pacemakers (LPs) have distinct physical and mechanical differences from TVP. The risk of P...

Tine-Based Leadless Pacemaker: Strategies for Safe Implantation in Unconventional Clini...
https://doi.org/10.1016/j.jacep.2020.08.021
JACC. Clinical Electrophysiology; Okabe T, Afzal MR et. al.

Oct 23rd, 2020 - Leadless pacemakers (LPs) have emerged as a meaningful alternative to transvenous pacemakers for single-ventricular pacing. LPs eliminate many of lead- and pocket-associated complications observed with transvenous pacemakers. Owing to the lack of ...

VVI pacing with normal QRS duration and ventricular function: MOST trial findings relev...
https://doi.org/10.1111/pace.14100
Pacing and Clinical Electrophysiology : PACE REFERENCES; Loring Z, North R et. al.

Oct 21st, 2020 - Leadless pacemakers (LPs) provide ventricular pacing without the risks associated with transvenous leads and device pockets. LPs are appealing for patients who need pacing, but do not need defibrillator or cardiac resynchronization therapy. Most i...

Ten year trends in cardiac implantable electronic devices in New Zealand: a national da...
https://doi.org/10.1111/imj.15103
Internal Medicine Journal; Foo FS, Stiles MK et. al.

Oct 18th, 2020 - Implant rates for cardiac implantable electronic devices (CIED), including permanent pacemakers (PPM) and implantable cardioverter defibrillators (ICD), have increased globally in recent decades. This is the first national study providing a contem...

Seventeen-year trend (2001-2017) in pacemaker and implantable cardioverter-defibrillato...
https://doi.org/10.1016/j.ejim.2020.09.003
European Journal of Internal Medicine; Zecchin M, Torre M et. al.

Sep 16th, 2020 - To analyze temporal trends (2001 -2017) of Pacemakers (PM) and Implantable Cardioverter-Defibrillators (ICD) procedures in Italy, according to the national Hospital Discharge Database (HDD). Frequency and implant rate (IR) in the Italian populatio...

see more →

News  19 results

Traditional Pacemaker Complications Down With Leadless Device
https://www.medpagetoday.com/cardiology/arrhythmias/73736

Jun 27th, 2018 - Patients who got the Nanostim leadless pacemaker instead of a transvenous one had fewer complications through up to 18 months of follow-up, researchers said. Those receiving the leadless cardiac pacemaker (LCP) generally had fewer complications th...

Cath Lab Recap: Killer Pacemakers; Heart Monitoring Underwear
https://www.medpagetoday.com/cardiology/pci/61949

Dec 8th, 2016 - Hacker-researchers were able to access ten types of implantable devices -- including pacemakers -- and find exploits that could possibly kill patients remotely from across a room. (The Register) The Abiomed Impella CP device won expanded FDA appro...

CMS to Cover Leadless Pacemakers ... But Only in Studies
https://www.medpagetoday.com/cardiology/arrhythmias/61440

Nov 14th, 2016 - The Centers for Medicare & Medicaid Services aims to cover leadless pacemakers, but only in the context of use in FDA-approved studies, according to a draft of the agency's national coverage determination for the devices. The document details the ...

Women Receive Far Fewer CIEDs Than Men but Have Higher Survival Rates After Implant
https://www.medscape.com/viewarticle/847145

Jun 28th, 2015 - MILAN, ITALY — Women are being short-changed when it comes to receiving cardiac implantable electronic devices (CIEDs), which is especially concerning because they actually have higher survival rates than men after implantation of certain device t...

FDA expands uses for cardiac resynchronization devices
https://www.mdedge.com/internalmedicine/article/81600/arrhythmias-ep/fda-expands-uses-cardiac-resynchronization-devices
Elizabeth Mechcatie

Apr 11th, 2014 - The approval of cardiac resynchronization pacemakers and defibrillators manufactured by Medtronic has been expanded to include patients with atrioventricular block and less severe heart failure, the Food and Drug Administration announced on April.

see more →

Patient Education  1 results see all →